Trial intelligence / Profile preview

Atorvastatin for Mild Traumatic Brain Injury

NCT01013870Phase 2Terminated

Sponsor
Baylor College of Medicine
Start
Feb 2010
Primary completion
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atorvastatin in traumatic brain injury (TBI), sponsored by Baylor College of Medicine. Started Feb 2010; status: terminated.

02

Drugs

atorvastatin
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT01013870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01013870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call